Better remedies for hepatitis C are becoming available in BC, but who’s going to pay for them?
New and more effective drugs to treat BC’s 50,000 hepatitis C patients would cost billions if covered under BC PharmaCare, but doctors say treating the patients for liver cancer or transplants could cost taxpayers even more.
Treatment options have improved dramatically for hepatitis C sufferers over the past few years, increasing efficacy and reducing side effects and length of treatment.
But the new drugs—at $640 a pill for one called Sovaldi—will cost up to $90,000 per patient over 12 weeks, according to doctors, and up to $110,000, according to BC Health.
Susan Lazaruk reports